SCHEMBL8337447

SCHEMBL8337447

O=C(O)CCC1(C(O)c2ccc(-c3ccccc3)cc2)NC(=O)NC1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAMTS5 Q9UNA0 3/20 0.41
MMP2 P08253 5/20 0.39
MMP9 P14780 4/20 0.39
MMP8 P22894 1/20 0.39
FFAR1 O14842 4/20 0.38
LMNA P02545 2/20 0.37
CYP1A2 P05177 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HIF1A Q16665 1/20 0.37
MMP3 P08254 1/20 0.36
ACP3 P15309 2/20 0.35
PTGS2 P35354 1/20 0.35
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
MMP14 P50281 1/20 0.33
ABCC4 O15439 1/20 0.33
GAA P10253 1/20 0.33
TSHR P16473 1/20 0.33
PTGS1 P23219 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6841039 0.87 MMP2 (0.38) ADAMTS5MMP2MMP9MMP8MMP3
SCHEMBL6839920 0.85 MMP2 (0.36) ADAMTS5MMP2MMP9MMP8FFAR1
SCHEMBL6842461 0.84 MMP2 (0.40) ADAMTS5MMP2MMP9MMP8FFAR1
SCHEMBL6799515 0.80 MMP2 (0.39) ADAMTS5MMP2MMP9MMP8FFAR1
SCHEMBL6791637 0.77 ADAM17 (0.50) ADAMTS5MMP2MMP9MMP8CYP1A2
SCHEMBL6787210 0.77 CYP3A4 (0.39) MMP2MMP9MMP8LMNACYP1A2
SCHEMBL6791760 0.77 MMP2 (0.34) ADAMTS5MMP2MMP9MMP8MMP3
SCHEMBL11933939 0.75 ADAM17 (0.48) ADAMTS5MMP2MMP9MMP8RAB9A
SCHEMBL6791581 0.74 MMP13 (0.36) ADAMTS5MMP2MMP9FFAR1MMP13
SCHEMBL6786868 0.72 HSD11B1 (0.33) ADAMTS5MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004024060-A2 METALLOPROTEINASE INHIBITORS AND INTERMEDIATES FOR PREPARATION THEREOF ASTRAZENECA AB (SE) 2004-03-25 WO disclosed